
-
EXACT SCIENCES CORP NASDAQ:EXAS A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.
Location: 5505 Endeavor Lane, Wisconsin, 53719, US | Website: www.exactsciences.com | Industry: Diagnostic Imaging Centers | Sector: Health Care and Social Assistance
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
11.12B
Cash
1.021B
Avg Qtr Burn
N/A
Short % of Float
5.41%
Insider Ownership
1.11%
Institutional Own.
96.67%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|